A deep tech and life sciences Venture Capital investment group

London, England
We’re excited to be a finalist at the @EISAssociation Awards 2025! In addition, 2 of our portfolio companies have been recognised - DeepTech Recycling MD’s Marvine Besong for Entrepreneur of the Year & @WandaHealth for Best EIS Investee Company
1
2
166
EMV Capital has published Interim Results for the six months ended 30 June 2026, reporting continued growth across the platform and further evidence of its capital-efficient venture-building model. Management will present the results at 14:00 BST today. investormeetcompany.com/emv-…
1
95
Our latest Virtual Meet the Portfolio event featured two companies approaching key milestones. It showed how our Venture Build model provides the strategic, regulatory and commercial support needed to reduce risk and create long-term value. Watch here: investormeetcompany.com/meet…
1
35
Great to see progress from @ProAxsis in its clinical study with @imperialcollege. The study could expand the use of its NEATstik® technology in the COPD market. @ILIAN_P_ILIEV and Dr Louise Ryan Murphy discuss its commercial strategy and growth plans. proactiveinvestors.co.uk/com…
1
67
A key shift in European VC is not just larger rounds, but how early they are happening. Global capital is moving faster into European deeptech, backing young companies developing frontier technologies. This reinforces EMV Capital’s focus on building IP-rich companies early.
2
63
Last week we hosted an investor dinner for portfolio company @VortexBioSci. The company shared recent progress across scientific validation, clinical collaborations and manufacturing, alongside the roadmap for the next stage of growth in precision oncology.
Made with AI
1
32
Don’t forget to join our Virtual Meet the Portfolio today at 14:00 BST. @AMRBioLtd's Nigel Brooksby and @ProAxsis' Louise Ryan Murphy will share recent progress, key milestones and their plans for the next stage of growth. Register for the event here: investormeetcompany.com/emv-…
1
34
We are hosting our third Virtual Meet the Portfolio session on Monday 27 July at 2:00pm on @InvestorMeetCo. The live session will provide investors with insight into EMV Capital and two portfolio companies, @AMRBioLtd and @ProAxsis. Register free here: investormeetcompany.com/emv-…
2
47
Congratulations to Glycotest and ProAxsis on reaching key growth milestones. Glycotest completed a $3.22m fundraising, while ProAxsis has reorganised its share capital ahead of a proposed EIS fundraise. Read more: lnkd.in/ePQErvVZ
1
109
An update from @AMRBio, our portfolio co. advancing a a Phase 3-ready antimicrobial that rapidly eliminates harmful bacteria before it develops. Next steps: FDA pathway guidance, manufacturing roadmap, and partnership conversations. Announcement here: londonstockexchange.com/news…
1
23
EMV Capital announces its 2025 Final Results, reporting continued progress despite ongoing VC and funding market challenges. Join management as they present the results live at 10:30 BST today: investormeetcompany.com/emv-… Read the full results here: polaris.brighterir.com/publi…
1
12
Join us for EMV Capital’s Final Results Presentation for the year ended 31 December 2025, tomorrow at 10:30 BST. Management will share full-year results and portfolio progress across the EMV Capital EIS Fund and Martlet Capital Fund. Register here: investormeetcompany.com/emv-…
1
16
Excited to invite you to a Virtual Meet the Portfolio session on Monday 1 December at 2:00pm GMT, hosted on @InvestorMeetCo. Join us to learn how we identify, support, and scale IP-rich companies - and hear directly from the founders. Register for free: investormeetcompany.com/emv-…
2
50
Delighted to announce the appointment of Anesh Patel as Group CFO with Stephen Crowe, the Company’s current CFO, transitioning to a newly created role of Portfolio CFO. Both will be instrumental to our continued growth. Read about the appointments here: polaris.brighterir.com/publi…
1
77
Sofant Technologies has achieved a world-first by demonstrating a fully functioning Ka-band transmit array using its proprietary RF MEMS beamforming IC at Tech Tour Defence in Paris - a pivotal moment for wireless innovation. #EMVCapital #SatCom #5G #6G #Defence
42
Great to see @IChronicle highlight our 2025 half year results, noting that we are trading at a "tantalising discount" - with a fair valuation three times our current share price. You can read the full article here: investorschronicle.co.uk/con…
26
We are delighted to announce further progress in our 2025 Interim Results. Highlights include: - AUM: £104.7m - £5m syndicated across 7 portfolio companies - Martlet Capital fully integrated - Destiny Pharma assets acquired View full set of results here: londonstockexchange.com/news…
54
In this interview our CEO discusses the acquisition of key Destiny Pharma assets. We are applying our Venture Build Programme to identify, acquire, and rebuild value in the XF-73 drug platform, in the fight against antimicrobial resistance. piped.video/watch?v=5m7XKQpq…
43
Excited to have acquired key assets from Destiny Pharma’s XF platform, incl. late-stage XF-73. This novel anti-infective targets post-surgical infections & antimicrobial resistance. #VentureCapital #HealthcareInnovation #AMR #LifeSciences
1
40
Delighted to announce that our portfolio company Wanda Health has secured £1.9M to scale remote patient monitoring and virtual care across the US. The investment round was led by EMV Capital Partners Ltd, and the funding will be used to accelerate growth. emvcapital.com/news/wanda-se…
1
29